This mouse tumor had four genes with non-silent mutations, Lrfn2, Smyd1, Ubn2 and Wdr11. We hypothesized that the mutations to these four genes may have facilitated tumor growth, and evaluated the function of each of these genes on G3 MB progression using in vivo systems. The gene discussed is LRFN2; the disease is neoplasm.